Dr. Volker Gerdts received a DVM in 1994 from Hanover Veterinary School and a German PhD equivalent from the Federal Research Institute for Animal Health, Island of Riems and Hanover Veterinary School, Germany, in 1997. A postdoctoral fellowship, funded by the German Research Council, was spent from 1998-2000 at VIDO-InterVac in the area of vaccine discovery and mucosal immunology. In 2002 Dr. Gerdts joined VIDO-InterVac as a Research Scientist. He was appointed Associate Director of Research in 2007, and became the Director and CEO in 2019.
Dr. Hancock is a leading microbiologist in Canada and has researched and taught at the University of British Columbia for nearly 40 years.
The fundamental interest of Hancock and his laboratory is in designing new therapeutic strategies to treat infections in the light of increasing antibiotic resistance coupled with a dearth of new antibiotic discovery.
Dr. Andrew Potter is internationally recognized for his work in the area of vaccine development. He is a graduate of Carleton University and the University of Otago in New Zealand. He has worked at the Vaccine and Infectious Disease Organization (VIDO) for the past 22 years, serving as a research scientist, Associate Director (Research) and Director. He currently holds an NSERC Senior Industrial Research Chair in the area of vaccine development.